Specificity of the rapid rK39 antigen-based immunochromatographic test Kalazar Detect(r) in patients with cutaneous leishmaniasis in Brazil
AUTOR(ES)
Molinet, Felix Javier Leon, Ampuero, Julia Sonia, Costa, Rodrigo Diniz, Noronha, Elza Ferreira, Romero, Gustavo Adolfo Sierra
FONTE
Mem. Inst. Oswaldo Cruz
DATA DE PUBLICAÇÃO
2013-05
RESUMO
The aim of this study was to evaluate the specificity of a rapid immunochromatographic test that was developed to detect antibodies against the rK39 antigen for the diagnosis of visceral leishmaniasis (VL). This evaluation was performed using sera from patients with a confirmed diagnosis of active cutaneous leishmaniasis. The sera from 272 patients with a confirmed diagnosis of localised cutaneous leishmaniasis (CL) who resided in an area endemic for Leishmania braziliensis in Brazil were obtained before the initiation of antileishmanial treatment. Kalazar Detect(r)(InBios, Seattle, WA) recombinant K39 antigen-based immunochromatographic strips were used according to the manufacturer's instructions. The test results were evaluated independently by two examiners in sequential order. The positive controls for the test included five serum samples from five patients with parasitologically confirmed diagnosis of VL caused by Leishmania infantum in Brazil. Overall, 100% of the samples obtained from patients with CL were negative, confirming the absence of a serological cross-reaction for individuals with cutaneous disease when these patients were evaluated using the rapid test. The lack of a cross-reaction in patients who were infected by parasites of the same genus highlights the specificity of the rK39 antigen for the diagnosis of VL in areas with the sympatric circulation of L. braziliensis and L. infantum.
Documentos Relacionados
- Evaluation of the direct agglutination test and the rK39 dipstick test for the sero-diagnosis of visceral leishmaniasis
- Estudo do teste rÃpido imunoenzimÃtico atravÃs do antÃgeno recombinante rk39 para diagnÃstico de leishmaniose visceral americana. correlaÃÃo clÃnico-terapÃutica
- rK39 Enzyme-Linked Immunosorbent Assay for Diagnosis of Leishmania donovani Infection
- Antigen-Based Therapy for the Treatment of Type 1 Diabetes
- Recombinant antigen-based immuno-slot blot method for serodiagnosis of syphilis